Stockscreener 앱 받기
13.75
9.78%
-1.49
시간 외 거래:
13.61
-0.14
-1.02%
전일 마감가:
$15.24
열려 있는:
$15.13
하루 거래량:
181.89K
Relative Volume:
1.14
시가총액:
$120.38M
수익:
$123.24M
순이익/손실:
$136.00K
주가수익비율:
-687.50
EPS:
-0.02
순현금흐름:
$-148.99M
1주 성능:
-19.87%
1개월 성능:
-33.22%
6개월 성능:
+42.78%
1년 성능:
-14.85%
1일 변동 폭
$13.75
$15.34
1주일 범위
$13.75
$17.37
52주 변동 폭
$6.53
$24.67
Seres Therapeutics Inc Stock (MCRB) Company Profile
명칭
Seres Therapeutics Inc
전화
617 945 9626
주소
200 SIDNEY STREET, CAMBRIDGE, MA
MCRB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MCRB
Seres Therapeutics Inc
|
13.75 | 133.42M | 123.24M | 136.00K | -148.99M | -0.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Seres Therapeutics Inc Stock (MCRB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-08 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2024-10-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-04-21 | 개시 | JP Morgan | Neutral |
| 2021-07-23 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-05-18 | 재개 | Goldman | Neutral |
| 2021-03-05 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2020-09-18 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-04-30 | 개시 | Jefferies | Hold |
| 2018-10-22 | 개시 | Chardan Capital Markets | Buy |
| 2017-10-13 | 개시 | Oppenheimer | Outperform |
| 2017-08-04 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-01 | 재확인 | FBR & Co. | Outperform |
| 2016-08-12 | 재확인 | FBR Capital | Outperform |
| 2016-08-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2016-08-01 | 재확인 | H.C. Wainwright | Buy |
| 2016-07-29 | 재개 | H.C. Wainwright | Buy |
| 2016-03-30 | 개시 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | Guggenheim | Buy |
| 2016-01-25 | 개시 | H.C. Wainwright | Buy |
| 2015-10-22 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2015-07-22 | 개시 | Canaccord Genuity | Buy |
| 2015-07-21 | 개시 | Goldman | Neutral |
| 2015-07-21 | 개시 | Leerink Partners | Outperform |
모두보기
Seres Therapeutics Inc 주식(MCRB)의 최신 뉴스
News impact scoring models applied to Seres Therapeutics Inc.2025 Dividend Review & Consistent Return Strategy Ideas - newser.com
Analyzing Seres Therapeutics Inc. with risk reward ratio chartsJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Signal strength of Seres Therapeutics Inc. stock in tech scannersPortfolio Value Summary & AI Based Buy/Sell Signal Reports - newser.com
Is Seres Therapeutics Inc. stock a buy on dipsTrade Volume Summary & Weekly High Momentum Picks - newser.com
Seres Therapeutics, Inc. (MCRB) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Seres Therapeutics, Inc.Common Stock (Nasdaq:MCRB) Stock Quote - FinancialContent
Will Seres Therapeutics Inc. (1S90) stock extend growth storyTrade Ideas & Daily Stock Trend Reports - newser.com
Is Seres Therapeutics Inc. stock supported by innovation pipeline2025 Volatility Report & Daily Growth Stock Investment Tips - newser.com
What market sentiment indicators show for Seres Therapeutics Inc. (1S90) stock - newser.com
How interest rate cuts could boost Seres Therapeutics Inc. stockJuly 2025 Patterns & AI Forecast Swing Trade Picks - newser.com
Can volume confirm reversal in Seres Therapeutics Inc.2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
Will Seres Therapeutics Inc. stock split attract more investorsJuly 2025 Spike Watch & Reliable Price Action Trade Plans - newser.com
Is Seres Therapeutics Inc. stock a contrarian buy2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com
Key metrics from Seres Therapeutics Inc.’s quarterly data2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
Published on: 2025-11-03 00:21:05 - newser.com
Published on: 2025-11-02 23:51:16 - newser.com
Is Seres Therapeutics Inc. stock recession proof2025 Year in Review & Daily Stock Trend Reports - newser.com
Analyzing Seres Therapeutics Inc. with multi timeframe chartsDollar Strength & Risk Managed Investment Strategies - newser.com
Institutional scanner results for Seres Therapeutics Inc.July 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Seres Therapeutics (MCRB) Price Target Decreased by 62.44% to 16.32 - MSN
Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving AverageTime to Sell? - MarketBeat
Is Seres Therapeutics Inc. stock attractive for hedge fundsEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Backtesting results for Seres Therapeutics Inc. trading strategiesWeekly Profit Report & Safe Capital Growth Stock Tips - newser.com
Net current asset value per share of Seres Therapeutics Inc – BX:MCRB - TradingView
Seres Therapeutics (MCRB) to Release Earnings on Wednesday - MarketBeat
Published on: 2025-11-01 01:46:58 - newser.com
How Seres Therapeutics Inc. (1S90) stock moves on employment dataExit Point & Daily Stock Trend Reports - newser.com
Operating cash flow per share of Seres Therapeutics Inc – BX:MCRB - TradingView
Is Seres Therapeutics Inc. (1S90) stock a buy before earnings resultsWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com
Published on: 2025-10-31 04:08:39 - newser.com
Seres Therapeutics, Inc. (MCRB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Leading vs lagging indicators on Seres Therapeutics Inc. performanceEarnings Overview Summary & Low Volatility Stock Suggestions - newser.com
Published on: 2025-10-30 06:05:42 - newser.com
Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025 - MarketScreener
Seres Therapeutics Inc (MCRB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):